Maravai Lifesciences Holdings (MRVI) Research & Development (2020 - 2026)

Maravai Lifesciences Holdings' Research & Development history runs 7 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Research & Development fell 20.44% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $16.4 million (down 14.02% YoY), while the FY2025 annual figure was $17.4 million, down 9.46% from the prior year.
• Research & Development was $3.9 million for Q1 2026 at Maravai Lifesciences Holdings, up from $3.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $5.4 million in Q3 2022 to a low of $3.7 million in Q1 2022.
• Historically, Research & Development has averaged $4.5 million across 5 years, with a median of $4.6 million in 2024.
• Biggest YoY gain for Research & Development was 176.93% in 2022; the steepest drop was 45.44% in 2022.
• A 5-year view of Research & Development shows it stood at $5.0 million in 2022, then dropped by 8.32% to $4.6 million in 2023, then fell by 0.72% to $4.6 million in 2024, then retreated by 16.95% to $3.8 million in 2025, then grew by 2.67% to $3.9 million in 2026.
• The last three Research & Development figures came in at $3.9 million (Q1 2026), $3.8 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.